RREB1 promotes prostate cancer by activating the transcription of SNHG4, which promotes DNA damage repair, the cell cycle, and resistance to the androgen-receptor antagonist enzalutamide [42]. This evidence concerns the gene SNHG4 and prostate carcinoma.